From GlobeNewswire: 2025-05-19 03:15:00

Alvotech has partnered with DNB Carnegie to provide liquidity services for its Swedish Depository Receipts on Nasdaq Stockholm. DNB Carnegie will help maintain liquidity by continuously quoting prices for Alvotech’s SDRs as per Nasdaq Stockholm’s requirements. The arrangement begins on May 20, 2025. Alvotech, a biotech company, focuses on developing biosimilar medicines and already has two biosimilars in the market. The company has a pipeline of nine biosimilar candidates for various disorders and has formed strategic partnerships for global reach. For more information, visit Alvotech’s website or follow them on social media.



Read more at GlobeNewswire: Alvotech Appoints DNB Carnegie as Liquidity Provider on